Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05082857 · ClinicalTrials.gov registry record · NA
(YMP) Young Moms Program
A NA study of Chronic Toxic Stress and Developmental/ Behavioral Regression in Young Children, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT05082857: Completed NA study of Chronic Toxic Stress and Developmental/ Behavioral Regression in Young Children, sponsored by Wake Forest University Health Sciences.
NCT05082857 is a NA study of Chronic Toxic Stress and Developmental/ Behavioral Regression in Young Children that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05082857, a NA study of Chronic Toxic Stress and Developmental/ Behavioral Regression in Young Children, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Young Moms Program (YMP) is designed to address systemic barriers to the health and stability of young moms and their children such as the lack of coordination of service delivery or logistical barriers within the health system. The YMP also streamlines the referral pipeline, connecting moms to evidence-based resources, and ensuring children complete all recommended assessments prior to kindergarten.
Primary Outcome
The Protective Factors Survey (PFS) is a 20-item measure - The PFS is a validated parent survey designed that assesses protective factors in five areas: family functioning/resiliency, social emotional support, concrete support, nurturing and attachment, and knowledge of parenting/child development - Each subscale is rated 1-7; higher is better - range is 35-175
Conditions Studied
Interventions
- BEHAVIORAL "traditional" Parents as Teachers (PAT)
- BEHAVIORAL "hybrid" PAT model
Study Locations (1)
North Carolina
- Wake Forest University Health Science - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-12-21 |
| Est. Completion | 2023-01-05 |
| Phase | NA |
What the finished NCT05082857 record still lists
NCT05082857 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Chronic Toxic Stress appearing as the primary indexed condition, and to 2 interventions - of which "traditional" Parents as Teachers (PAT) is the first listed.
NCT05082857 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05082857 about?
NCT05082857 is a clinical study titled "(YMP) Young Moms Program". Young Moms Program (YMP) is designed to address systemic barriers to the health and stability of young moms and their children such as the lack of coordination of service delivery or logistical barriers within the health system. The YMP also streamlines the referral pipeline, connecting moms to evid...
What is the current status of trial NCT05082857?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2021-12-21. Estimated completion is 2023-01-05.
What conditions does trial NCT05082857 study?
This clinical trial studies the following conditions: Chronic Toxic Stress, Developmental/ Behavioral Regression in Young Children.
What interventions are being tested in trial NCT05082857?
The interventions under investigation include: "traditional" Parents as Teachers (PAT) (BEHAVIORAL), "hybrid" PAT model (BEHAVIORAL).
Who is sponsoring clinical trial NCT05082857?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05082857 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05082857's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI